Stock Market News for September 24, 2026

Energy & Mining: tungsten deals, refinery restart and critical‑minerals finance

Fervo Energy (FRVO) reached a practical milestone with first power at Cape Station, reinforcing enhanced geothermal as a potential grid‑scale clean power source. Investors will watch operational ramp, permitting and offtake deals that determine when engineering success converts to revenue.

The Elmet Group (ELMT) will acquire a 4.99% stake in Masan High‑Tech Materials and enter a multi‑year tungsten supply partnership focused on the U.S. market, a strategic tie‑up that tightens critical mineral supply chains for defense and industrial customers.

Almonty Industries (ALM) and industry reports underscore that China remains the dominant tungsten supplier, pressuring Western buyers to secure alternate sources and accelerate project financing.

Sky Quarry (SKYQ) restarted Nevada’s only crude oil refinery, a near‑term production event that can affect regional fuel supply dynamics and margins for mid‑sized energy players.

FingerMotion (FNGR) provided an update on a 99 MW Alberta corridor, noting interest from potential offtakers for up to 52.5 MW. That commercial interest, if contracted, helps convert project development into predictable revenue for a small energy developer.

Greenland Mines (GRML) closed a $12‑per‑share equity financing, bolstering the balance sheet with $42 million to fund milestones through 2027.

Energy transition & battery supply

Fluence (FLNC) secured long‑term battery supply through a multiyear agreement with EVE Power, reducing execution risk on storage projects and improving project economics as developers lock components for multi‑year deployments.

TRISO‑X (XE) completed vertical construction of its TX‑1 fuel fabrication facility, a step toward scaling advanced nuclear fuel capacity for SMRs and long‑term decarbonization planning.

Space, defense and aerospace contract wins

Redwire (RDW) was selected for Space Systems Command’s $980 million NITE‑STAR IDIQ contract, strengthening backlog and government demand visibility in the space supply chain.

VisionWave Holdings (VWAV) received a conditional $20 million purchase order for 200 STRATUM VARAN unmanned ground vehicles—an order that could materially boost near‑term defense revenue if finalized.

Red Cat (RCAT) celebrated its inaugural Blue Ops Day in Georgia, highlighting a year of growth in U.S. maritime manufacturing and underscoring on‑shoring trends in defense supply chains.

Rocket Lab (RKLB) received shareholder approval for its acquisition of Iridium, a deal that will broaden Rocket Lab’s communications footprint and reshape competitive dynamics in satellite services. Investors should watch integration plans and revenue mix shifts as aerospace M&A activity accelerates.

Tech, crypto and enterprise: authentication, tokenization and autonomy

IonQ (IONQ) saw its Superion 256 platform selected by Florida International University, and separately announced Miami’s first quantum computer coming to FIU. Those endorsements validate IonQ’s commercialization pathway and broaden institutional access to qubit resources.

Quantum X Labs (QXL) filed a U.S. patent application for quantum authentication security technology, strengthening IP claims in post‑quantum identity and secure‑hardware markets.

Kodiak AI (KDK) and DTL Transport completed the first autonomous trucking deliveries under a new California DMV permit, a practical proof point for commercial autonomy and a potential step toward recurring regulated revenue for logistics automation providers.

CrowdStrike (CRWD) was named a leader in proactive security platforms by an independent research firm in a new evaluation. For investors, such recognition can support valuation multiple resilience as cybersecurity demand remains structural.

BitGo (BTGO) launched BitGo Research and named Greg Cipolaro head of research, aiming to deepen institutional crypto research capabilities. Near that theme, new market moves spotlight tokenization: BLSH reports a coalition of market infrastructure firms forming to advance issuer‑sponsored tokenized securities—an industry effort that could speed adoption of blockchain tools in capital markets.

Zhibao Technology (ZBAO) proposed a strategic partnership with DeSyn Protocol to build institutional‑grade BTCfi infrastructure and a yield ecosystem; that initiative ties into the broader tokenization and custody trend and could matter if it attracts institutional flows.

Maase Inc. (MAAS) signed a framework agreement to develop a Singapore‑based global AI services platform, a strategic push into Asia that could accelerate revenue diversification for a small AI services player.

Biotech & Pharma: designations, IND clearances and trial progress

Nuvectis (NVCT) announced Breakthrough Therapy designation in China for NXP200 in BRAF V600‑mutant high‑grade glioma, a regulatory priority that can accelerate access discussions ahead of pivotal data.

Prime Medicine (PRME) received U.S. FDA clearance of an IND for PM647 in alpha‑1 antitrypsin deficiency, advancing a gene‑editing candidate toward first‑in‑human testing and creating a clear clinical catalyst.

NeOnc (NTHI) landed new coverage as Roth flagged a potential 2026 trial catalyst, lifting visibility ahead of clinical inflection points.

Elicio Therapeutics (ELTX) landed a late‑breaking Phase 2 AMPLIFY‑7P data selection for an oral presentation at ESMO Congress 2026, raising visibility for its immune‑oncology portfolio.

Milestone Pharmaceuticals (MIST) enrolled the first Canadian participant in its ReVeRA‑301 Phase 3 pivotal trial evaluating etripamil nasal spray for AFib‑RVR, marking geographic expansion of a registrational study.

IMUNON (IMNN) highlighted a 14.7‑month overall survival signal and enrollment progress ahead of a Phase 3 IMNN‑001 study—data points that strengthen the company’s frontline case as it moves toward registrational testing.

Anavex (AVXL) shareholders re‑elected the board’s director slate at its annual meeting, removing a governance overhang and clarifying management continuity.

NanoBiotix (NBTX) provided a first‑half 2026 operational and financial update, giving investors fresh visibility into cash runway, program timelines and near‑term milestones. For biotech holders, such mid‑year updates are key to assessing dilution risks and development pacing ahead of clinical readouts.

Corporate finance & strategic moves

Viking Therapeutics (VKTX) priced an upsized $500 million offering, a capital raise with material dilution implications that funds late‑stage programs.

STAAR Surgical (STAA)’s board approved a $50 million share repurchase authorization. Buybacks can support EPS and signal confidence; investors will watch execution pace and funding sources.

Delek US Holdings (DK) announced a proposed offering of convertible senior notes, a financing that could shift leverage and investor focus for energy stakeholders.

Forward Industries (FWDI) completed a $25 million registered direct offering with an institutional investor, a capital infusion that reduces near‑term liquidity risk but dilutes existing holders.

AIFU announced a $135.0 million non‑brokered private placement, a sizable infusion that can materially extend runway and fund strategic initiatives; investors should track dilution terms and planned uses of proceeds.

Waldencast plc (WALD) filed a Form 25 to voluntarily delist from Nasdaq and deregister its securities under the Exchange Act, a move that shifts liquidity and disclosure requirements for shareholders and may prompt re‑allocation decisions by institutions.

Rezolute (RZLT) reported Q4 and full‑year fiscal 2026 results and provided a business update; investors will parse cash runway and development timelines for upcoming catalysts.

Celularity (CELU) closed an initial financing of more than $10 million as part of an up to $28 million recapitalization to accelerate growth after operating improvements.

Media, consumer and selected updates

Similarweb (APPS) named Michael Akkerman as CEO, a leadership change that could reset strategy and investor expectations around growth and product focus.

Optimum (OPTU) and A+E Global Media expanded a multi‑year distribution agreement to bring more entertainment to customers, a steadying revenue tie for cable and streaming bundles amid changing viewer habits.

Scholastic (SCHL) reported fiscal 2027 first‑quarter results. With consumer spending and school‑cycle seasonality in play, investors will watch revenue mix and margin trends for guidance into back‑to‑school periods.

YYForce (YFOR) issued first‑half 2026 results showing 26.8% revenue growth to US$32.7 million. Rapid top‑line growth at a smaller company can attract attention, but investors will look for margin progress and sustainable customer expansion.

Selected corporate and market updates to watch

• Greenland Mines execution on 2027 milestones and permit timelines.
• Delivery and backlog progress for Redwire, VisionWave and Voyager.
• Quantum and autonomy roadmap updates at IonQ, Quantum X Labs and Kodiak AI as qubit and commercialization milestones drive investor sentiment.
• Tokenization and crypto custody developments: industry coalition, BitGo research initiatives and Zhibao/DeSyn BTCfi plans could reshape institutional engagement with digital assets.
• Corporate finance watchlist: dilution and runway signals at Viking, AIFU, Celularity and the recent Forward Industries placement.
• Liquidity and listing status: Waldencast delisting to change market access and disclosure for holders.
• Biotech operational transparency: mid‑year updates such as NanoBiotix that clarify runway and timing for clinical catalysts.